Angeliq 0.5-1mg Tablets 28's
Overview
What is this medicine?
How to Use This Medicine
To get the most benefit from your medication, it's essential to follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely. Take your medication at the same time every day to establish a routine. You can take it with or without food, but if you experience stomach upset, taking it with food may help. Swallow the tablet whole - do not chew, break, or crush it. If you have difficulty swallowing, consult your doctor for guidance.
Storing and Disposing of Your Medication
To maintain the effectiveness and safety of your medication, store it at room temperature in a dry place, avoiding bathrooms and areas with high humidity. Keep all medications in a secure location, out of the reach of children and pets. When disposing of unused or expired medication, do not flush it down the toilet or pour it down the drain unless instructed to do so by your pharmacist or healthcare provider. Instead, check with your pharmacist for guidance on the best disposal method or explore local drug take-back programs.
What to Do If You Miss a Dose
If you miss a dose, take it as soon as you remember. However, if it has been more than 24 hours since the missed dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one. If you forget to take several doses, you may be at risk of bleeding - consult your doctor for advice on how to proceed.
Lifestyle & Tips
- Maintain a healthy diet rich in calcium and Vitamin D to support bone health.
- Engage in regular weight-bearing exercise to help prevent osteoporosis.
- Avoid smoking, as it increases the risk of blood clots, stroke, and heart attack.
- Limit alcohol consumption.
- Discuss any concerns about diet, exercise, or lifestyle with your healthcare provider.
Available Forms & Alternatives
Available Strengths:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention right away:
Allergic Reaction: Rash, hives, itching, red, swollen, blistered, or peeling skin with or without fever, wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
Liver Problems: Dark urine, tiredness, decreased appetite, upset stomach or stomach pain, light-colored stools, vomiting, or yellow skin or eyes.
Electrolyte Imbalance: Mood changes, confusion, muscle pain, cramps, or spasms, weakness, shakiness, change in balance, abnormal heartbeat, seizures, loss of appetite, or severe upset stomach or vomiting.
High Blood Pressure: Severe headache or dizziness, passing out, or changes in eyesight.
Gallbladder Problems: Pain in the upper right belly area, right shoulder area, or between the shoulder blades, yellow skin or eyes, fever with chills, bloating, or severe upset stomach or vomiting.
Pancreatitis: Severe stomach pain, severe back pain, or severe upset stomach or vomiting.
Neurological Symptoms: Weakness on one side of the body, trouble speaking or thinking, change in balance, drooping on one side of the face, or blurred eyesight.
Eye Problems: Changes in eyesight or loss, bulging eyes, or changes in how contact lenses feel.
Breast Changes: Lump in the breast, breast pain or soreness, or nipple discharge.
Vaginal Symptoms: Vaginal itching or discharge, or abnormal vaginal bleeding.
Mental Health Changes: Depression or other mood changes, memory problems, or loss.
Fluid Retention: Swelling, weight gain, or trouble breathing.
Blood Clots: Chest pain or pressure, coughing up blood, shortness of breath, swelling, warmth, numbness, change of color, or pain in a leg or arm, or trouble speaking or swallowing.
High Calcium Levels: Weakness, confusion, feeling tired, headache, upset stomach or vomiting, constipation, or bone pain (especially in people with cancer).
Common Side Effects
Most people do not experience serious side effects, but may have minor or mild side effects. If you experience any of the following, contact your doctor if they bother you or do not go away:
Headache
Diarrhea, upset stomach, or vomiting
Stomach pain or cramps
Bloating
Weight gain
Enlarged breasts
Tender breasts
Vaginal bleeding or spotting
Reporting Side Effects
This is not a complete list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Sudden severe headache, dizziness, or fainting
- Sudden vision changes (e.g., partial or complete loss of vision)
- Sudden numbness or weakness in your arm or leg, especially on one side of your body
- Chest pain or heaviness, pain spreading to arm or shoulder, nausea, sweating, general ill feeling (signs of heart attack)
- Sudden shortness of breath, coughing up blood (signs of blood clot in lungs)
- Pain, swelling, or tenderness in your leg (signs of blood clot in leg)
- New breast lump or changes in your breasts
- Unusual vaginal bleeding (e.g., bleeding that is heavy, persistent, or occurs after menopause has been established)
- Yellowing of your skin or eyes (jaundice)
- Severe stomach pain
- Symptoms of high potassium (e.g., muscle weakness, fatigue, slow heart rate, tingling in hands/feet)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction and its symptoms.
A history of certain health conditions, including:
+ Bleeding disorders
+ Blood clots or an increased risk of blood clots
+ Breast cancer
+ Kidney disease
+ Liver disease
+ Poor adrenal function
+ Heart attack
+ Stroke
+ Tumors that are sensitive to estrogen
Unexplained vaginal bleeding
Previous removal of the uterus (hysterectomy)
* Pregnancy or suspected pregnancy. Note: This medication should not be taken during pregnancy.
This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health issues with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
Precautions & Cautions
If you anticipate being immobile for extended periods, such as during long trips, bedrest after surgery, or illness, discuss this with your doctor, as prolonged immobility may increase your risk of developing blood clots.
If you have diabetes (high blood sugar), consult with your doctor, as this medication may affect your blood sugar levels. Monitor your blood sugar as directed by your doctor.
Additionally, if you are taking a salt substitute containing potassium, a potassium-sparing diuretic, or a potassium product, inform your doctor.
Be aware that medications like this one may cause high blood pressure. Have your blood pressure checked regularly, as advised by your doctor.
This drug may also lead to elevated triglyceride levels. If you have a history of high triglyceride levels, notify your doctor. Furthermore, have your blood work and other laboratory tests performed as scheduled by your doctor.
Regular breast exams, gynecology check-ups, and breast self-exams, as directed by your doctor, are crucial while taking this medication.
This medication may interfere with certain laboratory tests. Inform all your healthcare providers and laboratory personnel that you are taking this drug.
If you consume grapefruit juice or eat grapefruit frequently, discuss this with your doctor. Limit your alcohol intake and avoid smoking, as it increases the risk of heart disease. Consult with your doctor if you smoke.
If you are using this medication solely to treat vaginal dryness, itching, and burning, consult with your doctor to determine if a topical medication might be a more suitable option for you.
The risk of certain side effects, such as heart attack, stroke, breast cancer, ovarian cancer, and others, may vary depending on factors like the duration of estrogen use, whether it is taken with or without a progestin, and other individual factors. Discuss the benefits and risks of using this medication with your doctor.
If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects. If you are breastfeeding, consult with your doctor to discuss any potential risks to your baby.
Overdose Information
Overdose Symptoms:
- Nausea
- Vomiting
- Breast tenderness
- Dizziness
- Abdominal pain
- Drowsiness/fatigue
- Withdrawal bleeding (in females)
What to Do:
Seek immediate medical attention or call a poison control center (1-800-222-1222). Treatment is symptomatic and supportive; there is no specific antidote.
Drug Interactions
Contraindicated Interactions
- Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir, clarithromycin) in patients with renal impairment or high baseline potassium due to increased risk of hyperkalemia with drospirenone.
- Drugs that increase serum potassium (e.g., potassium-sparing diuretics, ACE inhibitors, ARBs, NSAIDs, heparin, aldosterone antagonists) in patients with renal impairment or high baseline potassium.
Major Interactions
- Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir, clarithromycin): May significantly increase estradiol and drospirenone exposure, leading to increased adverse effects.
- CYP3A4 inducers (e.g., carbamazepine, rifampin, phenytoin, phenobarbital, St. John's Wort): May decrease estradiol and drospirenone exposure, potentially reducing efficacy and increasing risk of breakthrough bleeding.
Moderate Interactions
- Moderate CYP3A4 inhibitors (e.g., erythromycin, diltiazem, verapamil): May increase estradiol and drospirenone exposure, requiring caution and monitoring.
- Thyroid hormone replacement therapy: Estrogens can increase thyroid-binding globulin (TBG), leading to increased circulating total thyroid hormone levels and potentially increased thyroid hormone dose requirements.
Minor Interactions
- Not specifically categorized as minor for this combination, but general drug interactions for estrogens and progestins apply.
Monitoring
Baseline Monitoring
Rationale: To identify contraindications, risk factors, and establish baseline health status.
Timing: Prior to initiation of therapy.
Rationale: To screen for breast cancer prior to initiating estrogen therapy.
Timing: Prior to initiation, and periodically thereafter as per standard guidelines.
Rationale: To assess cardiovascular risk factors.
Timing: Prior to initiation.
Rationale: To assess hepatic function, as the drug is contraindicated in severe hepatic impairment.
Timing: Prior to initiation.
Rationale: To assess baseline potassium levels, especially in patients with renal impairment or on concomitant potassium-sparing drugs, due to drospirenone's hyperkalemic potential.
Timing: Prior to initiation, and during the first treatment cycle if risk factors present.
Routine Monitoring
Frequency: Annually
Target: Normal for age and health status
Action Threshold: Significant changes or abnormalities warrant further investigation.
Frequency: Periodically, as per standard guidelines (e.g., every 1-2 years)
Target: No suspicious findings
Action Threshold: New masses, calcifications, or other suspicious findings require immediate follow-up.
Frequency: Periodically, especially during the first cycle and with concomitant use of potassium-sparing drugs or in patients with renal impairment.
Target: 3.5-5.0 mEq/L
Action Threshold: Potassium > 5.0 mEq/L or significant increase from baseline requires dose adjustment or discontinuation of Angeliq or concomitant medications.
Frequency: Regularly (e.g., every 3-6 months)
Target: <130/80 mmHg (or individualized target)
Action Threshold: Sustained elevation requires evaluation and management.
Symptom Monitoring
- Signs and symptoms of thromboembolic events (e.g., chest pain, shortness of breath, sudden severe headache, sudden vision changes, pain/swelling in leg)
- Signs and symptoms of breast cancer (e.g., new breast lump, nipple discharge, skin changes)
- Abnormal vaginal bleeding (e.g., persistent, recurrent, or heavy bleeding)
- Signs of liver dysfunction (e.g., jaundice, severe abdominal pain)
- Symptoms of hyperkalemia (e.g., fatigue, muscle weakness, bradycardia, paresthesias)
- Signs of allergic reaction (e.g., rash, itching, swelling, severe dizziness, trouble breathing)
Special Patient Groups
Pregnancy
Contraindicated in pregnancy. There is no indication for Angeliq in pregnancy, and there is evidence of fetal harm.
Trimester-Specific Risks:
Lactation
Not recommended during lactation. Estrogens and progestins are excreted in breast milk and may reduce the quantity and quality of breast milk. Potential adverse effects on the breastfed infant are unknown but possible.
Pediatric Use
Angeliq is not indicated for use in pediatric patients. Safety and efficacy have not been established in this population.
Geriatric Use
Use with caution in women 65 years of age or older. The WHIMS study showed an increased risk of probable dementia in women 65 years of age or older receiving combined estrogen and progestin therapy. Consider the lowest effective dose for the shortest duration. Closely monitor for cardiovascular events and cognitive changes.
Clinical Information
Clinical Pearls
- Angeliq contains drospirenone, a progestin with antimineralocorticoid activity, which can lead to hyperkalemia. Monitor serum potassium, especially in patients with renal impairment or those taking other potassium-sparing drugs (e.g., ACE inhibitors, ARBs, NSAIDs, potassium-sparing diuretics).
- This medication is for continuous combined therapy, meaning both hormones are taken daily without a break, which typically results in amenorrhea or infrequent, light bleeding after the initial adjustment period.
- Always use the lowest effective dose for the shortest duration consistent with treatment goals to minimize risks, especially cardiovascular events, stroke, and breast cancer.
- Patients should be advised to report any signs of blood clots (e.g., sudden chest pain, shortness of breath, leg pain/swelling), stroke (e.g., sudden severe headache, numbness/weakness on one side), or breast changes immediately.
- Regular follow-up appointments, including physical exams and mammograms, are crucial while on HRT.
Alternative Therapies
- Selective Serotonin Reuptake Inhibitors (SSRIs) or Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) for vasomotor symptoms (e.g., paroxetine, venlafaxine).
- Gabapentin for vasomotor symptoms.
- Clonidine for vasomotor symptoms.
- Bisphosphonates (e.g., alendronate, risedronate) for osteoporosis prevention/treatment.
- Selective Estrogen Receptor Modulators (SERMs) (e.g., bazedoxifene/conjugated estrogens, ospemifene) for specific menopausal symptoms or osteoporosis.
- Non-pharmacological interventions (e.g., lifestyle modifications, dietary changes, exercise) for menopausal symptoms and bone health.